Covered recipient · General Payments record
KARI LOWERY BRADSHAW
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$808.25
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $276.09 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $76.40 | 4 |
| Astellas Pharma US Inc | $47.67 | 3 |
| PFIZER INC. | $34.98 | 2 |
| ABBVIE INC. | $27.91 | 2 |
| Hologic Sales and Service, LLC | $22.02 | 1 |
| Corium, Inc. | $17.82 | 1 |
| Lilly USA, LLC | $17.23 | 1 |
| DEXCOM, INC. | $16.47 | 1 |
| Radius Health, Inc. | $15.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.46 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106813318 | CMS |
| ABBVIE INC. | $14.45 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106813320 | CMS |
| Astellas Pharma US Inc | $14.32 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139485248 | CMS |
| Astellas Pharma US Inc | $15.88 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139529738 | CMS |
| Astellas Pharma US Inc | $17.47 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139548707 | CMS |
| Corium, LLC | $17.82 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100104585 | CMS |
| Dexcom, Inc. | $16.47 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153369555 | CMS |
| Hologic Sales and Service, LLC | $22.02 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084885757 | CMS |
| Lilly USA, LLC | $17.23 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135725551 | CMS |
| Novo Nordisk Inc | $14.40 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100462964 | CMS |
| Novo Nordisk Inc | $19.52 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100329878 | CMS |
| Novo Nordisk Inc | $20.52 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100531623 | CMS |
| Novo Nordisk Inc | $21.96 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100584968 | CMS |
| PFIZER INC. | $16.85 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131465671 | CMS |
| PFIZER INC. | $18.13 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131970290 | CMS |
| Radius Health, Inc. | $15.59 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090025017 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.